Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (211-220 of 377) with videos related to

Pageof 38
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|March 23, 2016
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancerLuisa Carbognin, Isabella Sperduti, Matteo Brunelli, et al.
Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2011
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerAlessandra Fabi, Alessandra Felici, Giulio Metro, et al.
Vaccines|April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung CancerEmanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Frontiers in Oncology|July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case reportEttore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Cells|October 23, 2021
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone UnturnedLorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Genes|August 28, 2025
Genomics in Lung Cancer: A Scoping Review of the Role of ctDNA in Non-Advanced Non-Small-Cell Lung Cancer in the Prediction of Prognosis After Multimodality Therapeutic ApproachesCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" studyVincenzo Di Noia, Ettore D'Argento, Sara Pilotto, et al.
Pageof 38

Showing results (211-220 of 377) with videos related to

Sort By:
Pageof 38
Journal of Experimental & Clinical Cancer Research : CR|March 23, 2016
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancerLuisa Carbognin, Isabella Sperduti, Matteo Brunelli, et al.
Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2011
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerAlessandra Fabi, Alessandra Felici, Giulio Metro, et al.
Vaccines|April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung CancerEmanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Frontiers in Oncology|July 30, 2025
Enhanced response to dabrafenib plus trametinib in a patient with <i>BRAF</i> <sup>V600E</sup> lung cancer harboring an <i>RNF43</i> variant of unknown significance: a case reportEttore D'Argento, Antonio Vitale, Jacopo Russo, et al.
Cells|October 23, 2021
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone UnturnedLorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo, et al.
Recenti Progressi in Medicina|July 1, 2023
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]Gabriele Minuti, Alessio Stefani, Luca Trodella, et al.
Genes|August 28, 2025
Genomics in Lung Cancer: A Scoping Review of the Role of ctDNA in Non-Advanced Non-Small-Cell Lung Cancer in the Prediction of Prognosis After Multimodality Therapeutic ApproachesCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Lung Cancer (Amsterdam, Netherlands)|April 15, 2015
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patientsSebastiano Buti, Paola Bordi, Marcello Tiseo, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" studyVincenzo Di Noia, Ettore D'Argento, Sara Pilotto, et al.
Pageof 38